
Rate Cuts, Fiscal Resets, and AI Reality Checks
Merryn Talks Money
00:00
Stamp Duty Risks from US Listings
John raises concern that US secondary listings like AstraZeneca's reduce UK stamp duty revenue and demand policy response.
Play episode from 18:50
Transcript


